An efficient randomised trial design for multi-cancer screening blood tests: nested enhanced mortality outcomes of screening trial

Lancet Oncol. 2021 Oct;22(10):1360-1362. doi: 10.1016/S1470-2045(21)00204-7.
No abstract available

MeSH terms

  • Early Detection of Cancer
  • Hematologic Tests
  • Humans
  • Mass Screening
  • Neoplasms / blood
  • Neoplasms / diagnosis*
  • Neoplasms / mortality*
  • Randomized Controlled Trials as Topic*
  • Research Design*